Authors
Loading...
Retrospective study analyzes inflammasome activation in SJS/TEN, suggesting NLRP1 as a disease severity biomarker.
Kaya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: